It is a practitioner-grade, forward-looking addition for skin, cellular defence and healthy ageing, from a brand built for clinical use rather than the supplement aisle
Astegolimab, an anti-ST2, in chronic obstructive pulmonary disease (COPD-ST2OP): a phase 2a, placebo-controlled trial
GHK-Cu targets these cells directly
140 Mice lacking SIRT3 become more sensitive to the stimulation of several pharmacological or non-pharmacological stressors, showing symptoms, such as fibrosis, cardiac hypertrophy and high mortality
Natural products (NPs) constitute a valuable reservoir of compounds capable of triggering ICD
With exclusive monopoly rights, extensive promotional support, high-quality specialty healthcare products, attractive business margins, and dependable logistics support, Cafoli LifeCare Pvt Ltd helps franchise partners build a successful and profitable pharmaceutical business.